AMANDA BROWN: Open Payments
NPI 1982133625 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,492 in 166 payments from 21 companies in 2025. Trend: 2023 $624 · 2024 $3,151 · 2025 $3,492
Food & beverage: $3,492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $512 |
| Incyte Corporation | 20 | $458 |
| GENZYME CORPORATION | 12 | $390 |
| Janssen Biotech, Inc. | 14 | $359 |
| Regeneron Healthcare Solutions, Inc. | 12 | $351 |
| Novartis Pharmaceuticals Corporation | 22 | $207 |
| PFIZER INC. | 13 | $189 |
| Amgen Inc. | 11 | $149 |
| UCB, Inc. | 5 | $141 |
| LNHC, Inc | 1 | $121 |
Products named: DUPIXENT, OPZELURA, TREMFYA, SKYRIZI, RINVOQ, CIBINQO, COSENTYX, Otezla.
Industry payments across MI — which companies pay providers there.
